Skip to main content
Top
Published in: Clinical Oral Investigations 4/2019

01-04-2019 | Original Article

Performance status scale for head and neck scores for oral cancer survivors: predictors and factors for improving quality of life

Authors: Takahide Kondo, Akinari Sugauchi, Yusuke Yabuno, Hironobu Kobashi, Katsuhiko Amano, Tomonao Aikawa, Mikihiko Kogo, Masaya Okura

Published in: Clinical Oral Investigations | Issue 4/2019

Login to get access

Abstract

Objectives

This study aimed to determine the factors associated with long-term quality of life of oral cancer survivors.

Materials and methods

A total of 508 survivors were assessed using the performance status scale for head and neck (PSS-HN), which comprises Eating in Public (E-Public), Normalcy of Diet (N-Diet), and Understandability of Speech (U-Speech). Stepwise multiple linear regression analysis was performed.

Results

The median time between the end of treatment and participating in the survey was 38 months (range, 6–250). Overall, 57–60% of survivors achieved full performance (100 score) of each PSS-HN score, whereas 15% had moderate or severe impairment (≤ 50 score) in E-Public and N-Diet, and 4% had impairment in U-Speech. These three scores deteriorated with increasing T-stage. Age, soft tissue reconstruction, trismus, and missing occlusal contacts on the contralateral side were significantly associated with E-Public and N-Diet. Neck dissection, hard tissue reconstruction, and missing occlusal contacts bilaterally were associated with U-Speech score.

Conclusion

Older age, T4 tumor, and soft tissue reconstruction were predictors of low E-Public and N-Diet performance scores. Increasing mouth opening and maintaining optimal occlusal contacts on the contralateral side may be effective ways to improve N-Diet and E-Public performance. Maintaining optimal occlusal contacts bilaterally may be effective for improving speech performance.

Clinical relevance

Oral health care to increase optimal occlusal contacts and rehabilitation of trismus may be promising factors to improve the functional performance of oral cancer survivors.
Literature
3.
go back to reference List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, Vokes E (1997) Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 6(3):274–284CrossRefPubMed List MA, Mumby P, Haraf D, Siston A, Mick R, MacCracken E, Vokes E (1997) Performance and quality of life outcome in patients completing concomitant chemoradiotherapy protocols for head and neck cancer. Qual Life Res 6(3):274–284CrossRefPubMed
4.
go back to reference List MA, Ritter-Sterr C, Lansky SB (1990) A performance status scale for head and neck cancer patients. Cancer 66(3):564–569CrossRefPubMed List MA, Ritter-Sterr C, Lansky SB (1990) A performance status scale for head and neck cancer patients. Cancer 66(3):564–569CrossRefPubMed
6.
go back to reference Zelefsky MJ, Gaynor J, Kraus D, Strong EW, Shah JP, Harrison LB (1996) Long-term subjective functional outcome of surgery plus postoperative radiotheraphy for advanced stage oral cavity and oropharyngeal carcinoma. Am J Surg 171(2):258–261 discussion 262CrossRefPubMed Zelefsky MJ, Gaynor J, Kraus D, Strong EW, Shah JP, Harrison LB (1996) Long-term subjective functional outcome of surgery plus postoperative radiotheraphy for advanced stage oral cavity and oropharyngeal carcinoma. Am J Surg 171(2):258–261 discussion 262CrossRefPubMed
7.
go back to reference Klozar J, Lischkeova B, Betka J (2001) Subjective functional results 1 year after surgery and postoperative radiation for oropharyngeal carcinoma. Eur Arch Otorhinolaryngol 258(10):546–551CrossRefPubMed Klozar J, Lischkeova B, Betka J (2001) Subjective functional results 1 year after surgery and postoperative radiation for oropharyngeal carcinoma. Eur Arch Otorhinolaryngol 258(10):546–551CrossRefPubMed
11.
go back to reference Myers C, Kerr P, Cooke A, Bammeke F, Butler J, Lambert P (2012) Functional outcomes after treatment of advanced oropharyngeal carcinoma with radiation or chemoradiation. J Otolaryngol Head Neck Surg 41(2):108–118PubMed Myers C, Kerr P, Cooke A, Bammeke F, Butler J, Lambert P (2012) Functional outcomes after treatment of advanced oropharyngeal carcinoma with radiation or chemoradiation. J Otolaryngol Head Neck Surg 41(2):108–118PubMed
12.
go back to reference Xiao C, Zhang Q, Nguyen-Tan PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT BD (2017) Quality of life and performance status from a substudy conducted within a prospective phase 3 randomized trial of concurrent standard radiation versus accelerated radiation plus cisplatin for locally advanced head and neck carcinoma: NRG Oncology RTOG 0129. Int J Radiat Oncol Biol Phys 97(4):667–677. https://doi.org/10.1016/j.ijrobp.2016.07.020 CrossRefPubMed Xiao C, Zhang Q, Nguyen-Tan PF, List M, Weber RS, Ang KK, Rosenthal D, Filion EJ, Kim H, Silverman C, Raben A, Galloway T, Fortin A, Gore E, Winquist E, Jones CU, Robinson W, Raben D, Le QT BD (2017) Quality of life and performance status from a substudy conducted within a prospective phase 3 randomized trial of concurrent standard radiation versus accelerated radiation plus cisplatin for locally advanced head and neck carcinoma: NRG Oncology RTOG 0129. Int J Radiat Oncol Biol Phys 97(4):667–677. https://​doi.​org/​10.​1016/​j.​ijrobp.​2016.​07.​020 CrossRefPubMed
13.
go back to reference Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, Flentje M, Eckel HE, Mueller RP (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50(5):1161–1171CrossRefPubMed Staar S, Rudat V, Stuetzer H, Dietz A, Volling P, Schroeder M, Flentje M, Eckel HE, Mueller RP (2001) Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy--results of a multicentric randomized German trial in advanced head-and-neck cancer. Int J Radiat Oncol Biol Phys 50(5):1161–1171CrossRefPubMed
16.
go back to reference Yadav K, Nair D, Agarwal J, Chakrabarti S, Joshi S, Ingole P, Mishra A, Tathe N, Chaturvedi P (2016) Prevalence of functional problems after oral cavity malignancy treatment at a tertiary center: utilizing PSS HN (performance status scale for head and neck) scale. J Maxillofac Oral Surg 15(1):38–44. https://doi.org/10.1007/s12663-015-0805-2 CrossRefPubMed Yadav K, Nair D, Agarwal J, Chakrabarti S, Joshi S, Ingole P, Mishra A, Tathe N, Chaturvedi P (2016) Prevalence of functional problems after oral cavity malignancy treatment at a tertiary center: utilizing PSS HN (performance status scale for head and neck) scale. J Maxillofac Oral Surg 15(1):38–44. https://​doi.​org/​10.​1007/​s12663-015-0805-2 CrossRefPubMed
21.
Metadata
Title
Performance status scale for head and neck scores for oral cancer survivors: predictors and factors for improving quality of life
Authors
Takahide Kondo
Akinari Sugauchi
Yusuke Yabuno
Hironobu Kobashi
Katsuhiko Amano
Tomonao Aikawa
Mikihiko Kogo
Masaya Okura
Publication date
01-04-2019
Publisher
Springer Berlin Heidelberg
Published in
Clinical Oral Investigations / Issue 4/2019
Print ISSN: 1432-6981
Electronic ISSN: 1436-3771
DOI
https://doi.org/10.1007/s00784-018-2587-7

Other articles of this Issue 4/2019

Clinical Oral Investigations 4/2019 Go to the issue